For many years, cardiovascular disease was considered a male disease. Consequently, common data of registries, clinical trials and the like, were all reported for the entire patient population and only until recently has it become mandatory to report data on males and females separately.

Read full article (Cardiovasc Med 2023;26(3):67)

Cardiovascular (CV) diseases remain the leading cause of death globally, of which the majority are due to chronic and acute coronary syndromes (ACS).

Read full article (European Heart Journal: Acute Cardiovascular Care (2023) 00, 1–14)

Professor Thomas Lüscher, MD,  FRCP, FESC: awarded Honorary Membership of the Hungarian Society of Cardiology Balatonfüred, Hungary, May 11, 2023

Takotsubo syndrome (TTS) accounts for between 1 and 4% of cases presenting clinically as an acute coronary syndrome. It typically presents as a transient cardiac phenotype of left ventricular dysfunction with spontaneous recovery.

Read full article (Cardiovascular Research (2023) 00, 1–15)

An den Grand Rounds des Royal Brompton Hospital in London sprach Prof. Thomas Lüscher, London/Zürich, über die Errungenschaften der Kardiologie in den letzten Jahrzehnten und über ihre Zukunft.

Lesen Sie den ganzen Artikel (herz+gefäss _ 02 _ 2023)

In advanced cancer, cachexia is frequently observed in 30% to 80% of patients, depending on the cancer type, stage, and comorbidities.

This editorial refers to ‘20-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland

Following President Eisenhower’s heart attack on September 26, 1955,1 the spectrum of what we call today acute coronary syndromes (ACS) has markedly expanded.

Despite all efforts, cardiometabolic diseases, including obesity and diabetes and their cardiovascular (CV) complications such as myocardial infarction, stroke, and death, remain the main health issues worldwide.

Jede Tätigkeit muss sich heute einer Überprüfung stellen, so auch die Forschung. Ja, neben der Industrie sind staatliche Institutionen wie beispielswese der Schweizerische Nationalfonds, die Deutsche Forschunggemeinschaft, das National Institute of Health Research im United Kingdom and das National Institute of Health in den USA die wichtigsten Geldgeber.